Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Michael Pfleiderer"'
Autor:
Isabella Klasinc, Tanja Germerott, Ina Clasen, Mathies Breithaupt, Alexander Bornik, Martin Stenzel, Heinz-Peter Schlemmer, Kathrin Ogris, L. Oesterhelweg, Anna Heger, Ignaz Reicht, Roman Bux, Reinhard B. Dettmeyer, Sarah Heinze, Lena Maier-Hein, Clara-Sophie Schwarz, Sabine Schmid, Silke Grabherr, Thomas Widek, Markus Weber, Martin Urschler, David Simons, Marco Nolden, Axel Heinemann, Richard Dirnhofer, Kathrin Yen, Reingard Riener-Hofer, Katarzyna Michaud, Michael Tsokos, Thorsten Schwark, Michael T. Mund, Diana Nabers, Michael Pfeifer, Martine Schaul, Britta Gahr, Markus Große Perdekamp, Michael Pfleiderer, Philip Glemser, Caspar J. Goch, Eva Hassler, Martin Grassberger, Hansjürgen Bratzke, Paul Klinguer, Hubert Mara, Eva Scheurer, Astrid Krauskopf, Stefanie Ritz-Timme, Pia Genet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a47053d0982a242a385a8d21a86e2fb
https://doi.org/10.1055/b-004-132205
https://doi.org/10.1055/b-004-132205
Publikováno v:
Vaccine. 36:2364-2370
Introduction The governmental quality control of human vaccines is a long established tradition in many European countries. In Germany, vaccines have been controlled by a governmental agency since 1935. In the beginning, vaccine production and contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0b8c1408a6cb6dcb3fe25ffdfa58b3
https://doi.org/10.1016/j.vaccine.2018.02.078
https://doi.org/10.1016/j.vaccine.2018.02.078
Autor:
Kirsten S. Vannice, In-Kyu Yoon, Liliana Chocarro, Michael Pfleiderer, Joachim Hombach, Ahmed Bellah, Mike Ward
Publikováno v:
Vaccine. 35:5731-5733
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aec484178559a73d6106703697039f0c
https://doi.org/10.1016/j.vaccine.2017.07.044
https://doi.org/10.1016/j.vaccine.2017.07.044
Autor:
Michael Pfleiderer, Ole Wichmann
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58:263-273
Impfungen gehoren zu den effektivsten Praventionsmasnahmen der modernen Medizin und haben seit ihrer Einfuhrung im letzten Jahrhundert zu einem drastischen Ruckgang, in Einzelfallen sogar zur Eliminierung schwerer Infektionskrankheiten gefuhrt. Die N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::614588eb20171007763b0ea7a5b5a5f1
https://doi.org/10.1007/s00103-014-2109-y
https://doi.org/10.1007/s00103-014-2109-y
Autor:
Klaus Cichutek, David Wood, Xuguang Li, James Southern, Carolyn A. Wilson, Lindsay D Elmgren, Michael Pfleiderer, Yeowon Sohn, Robert Ball, Marco Cavaleri, Atsushi Kato, Junzhi Wang, Philip D. Minor, Teeranart Jivapaisarnpong, Elwyn Griffiths
Publikováno v:
Vaccine. 31:B163-B175
The Decade of Vaccines Collaboration and development of the Global Vaccine Action Plan provides a catalyst and unique opportunity for regulators worldwide to develop and propose a global regulatory science agenda for vaccines. Regulatory oversight is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::502b5a9447f99ae0cd8ab415fe122e48
Autor:
Anna Heger, David Simons, Heinz Peter Schlemmer, Michael Pfleiderer, Jan Tremper, Philip Glemser, Astrid Krauskopf, Kathrin Yen
Publikováno v:
International journal of legal medicine. 131(2)
The aim of this multi-reader feasibility study was to evaluate new post-processing CT imaging tools in rib fracture assessment of forensic cases by analyzing detection time and diagnostic accuracy. Thirty autopsy cases (20 with and 10 without rib fra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d0aa180602d88e5226701ff31addd1
https://pubmed.ncbi.nlm.nih.gov/27448110
https://pubmed.ncbi.nlm.nih.gov/27448110
Autor:
Michael Pfleiderer, Britta Neumann, Chantal Wallis, Nina Alex, John Wood, Ralf Wagner, Joanna Hammann, R.W. Newman, Constanze Göpfert
Publikováno v:
Vaccine. 30:4113-4122
Haemagglutination-inhibition (HI) and virus neutralisation (VN) assays are routinely applied to evaluate influenza vaccine immunogenicity for regulatory approval. Despite their frequent use both assays are currently only poorly standardised causing c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea81cd17fb10705aa670235e9d91cbc4
https://doi.org/10.1016/j.vaccine.2012.02.077
https://doi.org/10.1016/j.vaccine.2012.02.077
Autor:
Michael Pfleiderer
Publikováno v:
Pharmazie in unserer Zeit. 40:126-134
Influenza-Impfstoffe sind seit vielen Jahrzehnten verfugbar. Ihr breiter Einsatz, der sich insbesondere auf die offentlichen Impfempfehlungen stutzt, hat sich jedoch erst in den letzten 15 bis 20 Jahren etabliert. Dies ist insbesondere aus den stetig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4ed857c0c457c64cbab01dfa2fb9cab
https://doi.org/10.1002/pauz.201100407
https://doi.org/10.1002/pauz.201100407
Autor:
Michael Pfleiderer
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 53:1242-1249
The concept of identifying appropriate scientific and regulatory principles to ensure rapid availability of pandemic influenza vaccines when needed were already developed starting in the year 2003. These principles allowed licensing of three so-calle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee51938b0d43d1cadf157b1b687974cf
https://doi.org/10.1007/s00103-010-1161-5
https://doi.org/10.1007/s00103-010-1161-5
Publikováno v:
Nature Biotechnology
Several factors should be taken into account when it comes to the first exposure of humans to a novel vaccine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e16e93ae60e6a33e1a2180b8800b9c
https://doi.org/10.1038/nbt0910-910
https://doi.org/10.1038/nbt0910-910